An Evaluation of a Self-contained Direct Digital Radiography System for Breast Specimen Imaging

NCT ID: NCT01379092

Last Updated: 2012-03-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-06-30

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the image quality and operation of a self-contained direct digital radiography system for breast specimen imaging.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Specimen imaging is an accepted method for evaluating tissue specimens which are obtained either through minimally-invasive breast needle biopsy (MIBB) or breast surgery. Specimen imaging is used to confirm the targeting and sampling adequacy of radiographically apparent breast abnormalities. Specimen images are acquired and then compared to the routine and diagnostic imaging to provide radiographic evidence that the index lesion was adequately targeted and sampled (as in the case of MIBB) or targeted and removed with adequate margins \[as in the case of breast surgical specimens (BSS)\]. Specimen imaging also provides guidance to the histopathologist when evaluating the breast specimen.

Near real-time image acquisition, review and feedback is essential for specimen imaging. The patient typically remains in compression on the biopsy table for MIBB or under anesthesia for BSS until the clinician has confirmation that the index abnormality has been adequately sampled (in the case of MIBB) or surgically excised. For this reason, digital techniques are favored over analog (film) counterparts because of the immediacy of image acquisition and transfer and display to the radiologist for review.

Image quality and speed are critical factors in specimen imaging. High resolution images are a clinical requirement to delineate the features and extent of mass lesions, and presence and extent of microcalcifications.

Conventional full-field digital (FFDM) mammographic equipment located in the mammography department is one accepted approach for specimen imaging. An advantage of this method is that a licensed and skilled mammographic technologist assures the adequate exposure of specimens. However, this method requires that the FFDM system be free at the time the specimen arrives in the mammography department, interfering with mammogram schedules. In the case of BSS, the use of conventional FFDM systems additionally requires the transport of specimens to the mammography department, adding significant time that the patient is under anesthesia.

Another mode for specimen radiography is self-contained digital radiography specimen imaging systems that are located in the mammography department or in the Operating Room (intraoperative). The use of self-contained digital systems frees the conventional mammography system for its intended purpose, while providing the clinician all the speed of digital radiography.

It has been shown that intraoperative imaging significantly reduces the amount of time that the patient is under anesthesia.

Although, self-contained digital radiography specimen imaging systems provide an advantage in speed, resulting images may suffer in image quality and despite the availability of intraoperative self contained systems, many clinicians choose to transfer specimens to the mammography department for imaging on a conventional FFDM system. Current specimen radiography systems employ an indirect digital technique, a two step conversion, where incoming x-ray signal is converted to light and then to digital signal. The intermediate step of converting signal to light, leads to diffusion and scatter over many pixels and this in turn leads to degradation of the very fine features of mass densities and microcalcifications.

Direct Digital technique is another method currently used in breast imaging. The direct digital technique has the advantage of converting incoming signal directly to digital signal, avoiding the intermediary light conversion phase of indirect exposure. The direct to digital process results in better use of incoming signal and greater resolution and thus a sharper image, providing high resolution of minute features associated with mass lesions and microcalcifications.

Another common characteristic of current self-contained systems is the use of "stitching" many small CMOS chips to create a larger image detector. This type of tiling provides for a more economical system, but shearing effects, gaps between chips and overall concerns with calibration of multiple chips significantly degrades image quality.

All digital images, indirect or direct are acquired in a raw state and processed to allow review. While image processing cannot improve or change the raw aspects of the image after acquisition, processing can improve the visibility of features available in the image. Image processing is fundamentally associated with image acquisition technique. If the image is not adequately exposed, image processing will not be optimally applied and in some cases fail, requiring additional imaging.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Breast biopsy specimen imaging & comparison of image quality

Each subject's explanted tissue will serve as both the control (standard analysis) and the experimental analysis of the quality of the images.

Group Type EXPERIMENTAL

Trident Specimen Radiography System

Intervention Type DEVICE

MIBB images will be acquired on the standard of care device and the Trident System in the Breast Center at Hoag Hospital. BSS images will be acquired on standard of care device in the Operating Room and/or the Breast Center at Hoag Hospital and then on the Trident System. Image quality will be compared and system operation will be evaluated. Feedback will be provided to manufacturer and the Trident System further refined.

Bioptics, Faxitron, and Full Field Digital Mammography (FFDM) Selenia

Intervention Type DEVICE

All the above devices are used for SOC BSS imaging at Hoag Hospital. The images captured from these devices will be compared to the images captured from the Trident Specimen Radiography device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trident Specimen Radiography System

MIBB images will be acquired on the standard of care device and the Trident System in the Breast Center at Hoag Hospital. BSS images will be acquired on standard of care device in the Operating Room and/or the Breast Center at Hoag Hospital and then on the Trident System. Image quality will be compared and system operation will be evaluated. Feedback will be provided to manufacturer and the Trident System further refined.

Intervention Type DEVICE

Bioptics, Faxitron, and Full Field Digital Mammography (FFDM) Selenia

All the above devices are used for SOC BSS imaging at Hoag Hospital. The images captured from these devices will be compared to the images captured from the Trident Specimen Radiography device.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Breast specimens acquired through MIBB or Surgical techniques arriving for specimen imaging

Exclusion Criteria

* Breast specimens that are larger than12 x 14 cm.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hologic, Inc.

INDUSTRY

Sponsor Role collaborator

Levine, Gary M. , M.D.

INDIV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gary M Levine, M.D.

Director of Breast Imaging

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gary M. Levine, M.D.

Role: PRINCIPAL_INVESTIGATOR

Hoag Memorial Hospital Presbyterian

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hoag Memorial Hospital Presbyterian

Newport Beach, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gary M. Levine, M.D.

Role: CONTACT

949-764-5780

Cheryl M. Hanna, R.N.

Role: CONTACT

949-764-4537

References

Explore related publications, articles, or registry entries linked to this study.

Silverstein MJ, Lagios MD, Recht A, Allred DC, Harms SE, Holland R, Holmes DR, Hughes LL, Jackman RJ, Julian TB, Kuerer HM, Mabry HC, McCready DR, McMasters KM, Page DL, Parker SH, Pass HA, Pegram M, Rubin E, Stavros AT, Tripathy D, Vicini F, Whitworth PW. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2005 Oct;201(4):586-97. doi: 10.1016/j.jamcollsurg.2005.05.032. No abstract available.

Reference Type BACKGROUND
PMID: 16183499 (View on PubMed)

Kaufman CS, Jacobson L, Bachman BA, Kaufman LB, Mahon C, Gambrell LJ, Seymour R, Briscoe J, Aulisio K, Cunningham A, Opstad F, Schnell N, Robertson J, Oliver L. Intraoperative digital specimen mammography: rapid, accurate results expedite surgery. Ann Surg Oncol. 2007 Apr;14(4):1478-85. doi: 10.1245/s10434-006-9126-5. Epub 2007 Jan 18.

Reference Type BACKGROUND
PMID: 17235716 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-01-LEV

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tomosynthesis Mammographic Imaging Screening Trial
NCT02616432 ACTIVE_NOT_RECRUITING NA